EUVIMEDSkopri EUVIMED
Open access

Dynamic Hippo pathway activity underlies mesenchymal differentiation during lung alveolar morphogenesis

Fatima N Chaudhry iD, Sylvia N Michki iD, Dain L Shirmer, Sharon McGrath-Morrow iD, Lisa R Young, David B Frank, Jarod A Zepp iD

Development · 2024

DOI: 10.1242/dev.202430 ↗

At a glance

Journal article in Development, 2024. Written by Fatima N Chaudhry and 6 co-authors. Institution: Division of Pulmonary and Sleep Medicine, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. Major MEDLINE topics: Cell Differentiation, Hippo Signaling Pathway, Myofibroblasts, YAP-Signaling Proteins. Cited 10 times so far (Crossref); 84 references. The full text is freely available in PubMed Central. Funded by: NIGMS NIH HHS, NHLBI NIH HHS, NIH HHS.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Alveologenesis, the final stage in lung development, substantially remodels the distal lung, expanding the alveolar surface area for efficient gas exchange. Secondary crest myofibroblasts (SCMF) exist transiently in the neonatal distal lung and are crucial for alveologenesis. However, the pathways that regulate SCMF function, proliferation and temporal identity remain poorly understood. To address this, we purified SCMFs from reporter mice, performed bulk RNA-seq and found dynamic changes in Hippo-signaling components during alveologenesis. We deleted the Hippo effectors Yap/Taz from Acta2-expressing cells at the onset of alveologenesis, causing a significant arrest in alveolar development. Using single cell RNA-seq, we identified a distinct cluster of cells in mutant lungs with altered expression of marker genes associated with proximal mesenchymal cell types, airway smooth muscle and alveolar duct myofibroblasts. In vitro studies confirmed that Yap/Taz regulates myofibroblast-associated gene signature and contractility. Together, our findings show that Yap/Taz is essential for maintaining functional myofibroblast identity during postnatal alveologenesis.

Subjects

MeSH terms (MEDLINE)

Cell DifferentiationHippo Signaling PathwayMyofibroblastsYAP-Signaling ProteinsPulmonary AlveoliSignal TransductionProtein Serine-Threonine KinasesMorphogenesisAnimalsMiceMesodermAdaptor Proteins, Signal TransducingLungOrganogenesisGene Expression Regulation, Developmental

Author keywords

AlveologenesisFibroblastHippoLungMesenchymeMouseYap/Taz

Substances

YAP-Signaling ProteinsYap1 protein, mouseProtein Serine-Threonine KinasesWwtr1 protein, mouseAdaptor Proteins, Signal Transducing

Authors and institutions

  • Division of Pulmonary and Sleep Medicine, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
  • Division of Cardiology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.

ORCID profiles: Fatima N Chaudhry, Sylvia N Michki, Sharon McGrath-Morrow, Jarod A Zepp

Funding

  • NIGMS NIH HHS
  • NHLBI NIH HHS
  • NIH HHS
  • National Institutes of Health
  • Children's Hospital of Philadelphia

Cite

APA

Chaudhry, F. N., Michki, S. N., Shirmer, D. L., McGrath-Morrow, S., Young, L. R., Frank, D. B., & Zepp, J. A. (2024). Dynamic Hippo pathway activity underlies mesenchymal differentiation during lung alveolar morphogenesis. Development. https://doi.org/10.1242/dev.202430

Vancouver

Chaudhry FN, Michki SN, Shirmer DL, McGrath-Morrow S, Young LR, Frank DB, et al. Dynamic Hippo pathway activity underlies mesenchymal differentiation during lung alveolar morphogenesis. Development. 2024. doi:10.1242/dev.202430

BibTeX
@article{Chaudhry2024,
  author = {Chaudhry, Fatima N and Michki, Sylvia N and Shirmer, Dain L and McGrath-Morrow, Sharon and Young, Lisa R and Frank, David B and Zepp, Jarod A},
  title = {Dynamic Hippo pathway activity underlies mesenchymal differentiation during lung alveolar morphogenesis},
  journal = {Development},
  year = {2024},
  doi = {10.1242/dev.202430}
}
Start for free →